{
  "id": 10869568,
  "title": "Mayne Pharma Settles IMVEXXY Patent Litigation With Sun Pharma",
  "url": "https://urgent.news/2026/09/30/mayne-pharma-settles-imvexxy-patent-litigation-with-sun-pharma",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-30T05:01:03.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/mayne-pharma-settles-imvexxy-patent-litigation-sun-pharma"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Mayne Pharma Group Limited (MYX.AX) has reached settlement with Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS), resolving the Paragraph 1V patent litigation concerning IMVEXXY (estradiol vaginal inserts) and its U.S. FDA Orange Book-listed patents.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}